Counsel Health
-7%
est. 2Y upside i
Counsel Health is an AI-enabled virtual care company that combines medical AI with in-house physicians to deliver immediate, personalized guidance for nearly any medical concern.
Rank
#2464
Sector
HealthTech
Est. Liquidity
~5Y
Data Quality
Data: LowThe equity upside is highly uncertain due to lack of financial data.
Last updated: July 3, 2026
If Counsel Health achieves category leadership through AI differentiation and IPO window opens, valuation could triple to ~$465M. However, this requires revenue scaling to justify multiple expansion.
Moderate revenue growth and convergence to public comp multiples yields ~50% valuation increase to $232.5M, net of ~20% dilution from follow-on financing.
Intense competition from Teladoc, Big Tech, and others suppresses growth; exit below $36M total funding wipes out common equity due to 1x preference.
Preference Stack Risk
highFunding Intensity
0%$36M total funding creates a 23% preference overhang on $155M valuation, meaning common stock is significantly diluted in downside scenarios.
Dilution Risk
moderateGiven Series A and moderate capital intensity, another raise within 2 years is likely, diluting common holders by ~20%.
Secondary Liquidity
noneNo secondary market activity; liquidity is contingent on IPO or acquisition, likely 5+ years out.
Questions to Ask at the Interview
Strategic questions based on Counsel Health's data — designed to show you've done your homework.
- 1
“What specific revenue growth metrics and margin targets do you have for the next 12-18 months?”
- 2
“How do you plan to compete against Big Tech's healthcare initiatives while maintaining your AI moat?”
- 3
“What is the typical vesting schedule and what liquidity events are realistically expected for employees?”
Community
Valuation Sentiment
Our model estimates -7% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.